Patents by Inventor Betsy Denise REZNER

Betsy Denise REZNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for immune cell modulation in adoptive immunotherapies
    Patent number: 11932870
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: March 19, 2024
    Inventors: Jonathan Rosen, Betsy Denise Rezner, Ian Hardy, Eigen Peralta
  • Stem cell culture media and methods of enhancing cell survival
    Patent number: 11135244
    Abstract: The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: October 5, 2021
    Assignee: Fate Therapeutics, Inc.
    Inventor: Betsy Denise Rezner
  • COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
    Publication number: 20200181573
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Application
    Filed: December 4, 2017
    Publication date: June 11, 2020
    Inventors: Jonathan Rosen, Betsy Denise Rezner, Ian Hardy, Eigen Peralta
  • MODULATION OF T LYMPHOCYTES
    Publication number: 20190119635
    Abstract: The present disclosure relates to molecular biology, cell biology and immunology. Specifically, the present disclosure provides compositions and methods for modulating an isolated population of T lymphocytes to improve the therapeutic potential thereof.
    Type: Application
    Filed: May 4, 2016
    Publication date: April 25, 2019
    Inventors: David Robbins, Betsy Denise Rezner, Lisa Guerrettaz, Leah Mitchell
  • STEM CELL CULTURE MEDIA AND METHODS OF ENHANCING CELL SURVIVAL
    Publication number: 20180193381
    Abstract: The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 12, 2018
    Inventor: Betsy Denise Rezner
  • Stem cell culture media and methods of enhancing cell survival
    Patent number: 9943545
    Abstract: The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 17, 2018
    Assignee: Fate Therapeutics, Inc.
    Inventor: Betsy Denise Rezner
  • STEM CELL CULTURE MEDIA AND METHODS OF ENHANCING CELL SURVIVIAL
    Publication number: 20150044176
    Abstract: The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 12, 2015
    Applicant: FATE THERAPEUTICS, INC.
    Inventor: Betsy Denise REZNER